AstraZeneca, Sanofi, Eli Lilly sue HHS over 340B opinion

Eli Lilly, Sanofi and AstraZeneca have all filed lawsuits asking courts to reverse an advisory opinion released by HHS stating that 340B discounts apply to contract pharmacies, Bloomberg Law reported.

The drugmakers argue the advisory opinion, which HHS released Dec. 30, is unlawful and requires them to honor a practice that isn't covered under the 340B statute. Advisory opinions don't carry the force of a law, but they guide how HHS enforces the program